Influences of apolipoprotein E polymorphism on the response of plasma lipids to the Ad libitum consumption of a high-carbohydrate diet compared with a high-monounsaturated fatty acid diet

被引:17
作者
Couture, P
Archer, WR
Lamarche, B
Landry, N
Dériaz, O
Corneau, L
Bergeron, J
Bergeron, N
机构
[1] CHU Laval, Ctr Rech, Lipid Res Ctr, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Nutraceut & Funct Foods Inst, Laval, PQ, Canada
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2003年 / 52卷 / 11期
基金
加拿大健康研究院;
关键词
D O I
10.1016/S0026-0495(03)00275-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to assess the contribution of the apolipoprotein E (apoE) polymorphism and factors, such as age and waist circumference, to variations in plasma low-density lipoprotein-cholesterol (LDL-C) response following ad libitum consumption of a diet rich in complex carbohydrates (high-CHO: 58% of energy as CHO) versus a diet rich in fat and monounsaturated fatty acids (high-MUFA: fat, 40% of energy and 22% as MUFA). Sixty-five men participated in this parallel 6- to 7-week study involving either a high-CHO or a high-MUFA diet. Fasting plasma lipid profile and anthropometry were determined at the beginning and at the end of the dietary period. The high-CHO and high-MUFA diets both induced significant (P < .01) and comparable reductions in body weight and waist circumference. These changes were associated with a significant (P < .01) and comparable decrease in LDL-C (-19% and -16%, respectively). Stepwise multiple regression analyses showed that 32% of the variation in the LDL-C response to the high-CHO diet was attributable to the apoE polymorphism (18.5%, P = .04) and waist circumference (13.5%, P = .03) indicating that men with a waist circumference greater than 100 cm and the E2 allele had the greatest reduction in plasma LDL-C after the high-CHO diet. On the other hand, in the high-MUFA group, waist circumference was the only significant contributing factor to the LDL-C response and accounted for 44.5% of its variance. In conclusion, the plasma LDL-C response to ad libitum comsumption of a high-CHO and a high-MUFA diets are not modulated to the same extent by the apoE polymorphism and waist circumference. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1454 / 1459
页数:6
相关论文
共 25 条
  • [1] BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
  • [2] Bohnet K, 1996, J LIPID RES, V37, P1316
  • [3] SUR UN DOSAGE RAPIDE DU CHOLESTEROL LIE AUX ALPHA-LIPOPROTEINES ET AUX BETA-LIPOPROTEINES DU SERUM
    BURSTEIN, M
    SAMAILLE, J
    [J]. CLINICA CHIMICA ACTA, 1960, 5 (04) : 609 - 609
  • [4] CARDIN AD, 1984, J BIOL CHEM, V259, P8522
  • [5] Individual cholesterol variation in response to a margarine- or butter-based diet - A study in families
    Denke, MA
    Adams-Huet, B
    Nguyen, AT
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (21): : 2740 - 2747
  • [6] Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia
    Dong, LM
    Parkin, S
    Trakhanov, SD
    Rupp, B
    Simmons, T
    Arnold, KS
    Newhouse, YM
    Innerarity, TL
    Weisgraber, KH
    [J]. NATURE STRUCTURAL BIOLOGY, 1996, 3 (08): : 718 - 722
  • [7] APOLIPOPROTEIN-E ISOFORM PHENOTYPE AND LDL SUBCLASS RESPONSE TO A REDUCED-FAT DIET
    DREON, DM
    FERNSTROM, HA
    MILLER, B
    KRAUSS, RM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (01) : 105 - 111
  • [8] PHENOTYPIC EFFECTS OF APOLIPOPROTEIN STRUCTURAL VARIATION ON LIPID PROFILES .3. CONTRIBUTION OF APOLIPOPROTEIN-E PHENOTYPE TO PREDICTION OF TOTAL CHOLESTEROL, APOLIPOPROTEIN-B, AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL IN THE HEALTHY WOMEN STUDY
    EICHNER, JE
    KULLER, LH
    FERRELL, RE
    MEILAHN, EN
    KAMBOH, MI
    [J]. ARTERIOSCLEROSIS, 1990, 10 (03): : 379 - 385
  • [9] ABNORMAL INVIVO METABOLISM OF APOLIPOPROTEIN-E4 IN HUMANS
    GREGG, RE
    ZECH, LA
    SCHAEFER, EJ
    STARK, D
    WILSON, D
    BREWER, HB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (03) : 815 - 821
  • [10] GREGG RE, 1984, J LIPID RES, V25, P1167